This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Paul Nioi: Innovator in RNAi Technology
Introduction
Paul Nioi is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of RNA interference (RNAi) technology. His work focuses on developing innovative solutions for genetic disorders associated with solute carrier family members.
Latest Patents
Paul Nioi holds a patent for "Solute carrier family member iRNA compositions and methods of use thereof." This invention relates to RNAi agents, specifically double-stranded RNA (dsRNA) agents, that target solute carrier family member genes such as SLC30A10 and SLC39A8. The patent outlines methods for using these RNAi agents to inhibit the expression of these genes and offers potential treatments for disorders like hypermanganesemia.
Career Highlights
Paul Nioi is currently associated with Alnylam Pharmaceuticals, Inc., where he continues to advance his research in RNAi technology. His work has the potential to impact the treatment of various genetic disorders, showcasing his commitment to innovation in the biomedical field.
Collaborations
Some of his notable coworkers include Lucas D Ward and Ho-Chou Tu, who collaborate with him on various projects within the company.
Conclusion
Paul Nioi's contributions to RNAi technology and his innovative patent demonstrate his dedication to advancing medical science. His work at Alnylam Pharmaceuticals, Inc. positions him as a key player in the development of treatments for genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile